EQL Pharma AB (publ) (STO:EQL)
Sweden · Delayed Price · Currency is SEK 26.30
+1.15 (4.57%)
At close: Aug 14, 2026
EQL Pharma AB Financials Overview
Financials in millions SEK. Fiscal year is April - March.
Millions SEK. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 432.35 | 432.66 | 373.52 | 264.17 | 259.91 | 409.75 |
Revenue Growth | 8.65% | 15.83% | 41.39% | 1.64% | -36.57% | 128.73% |
Gross Profit Gross Profit Growth | 134.53 | 162.84 | 155.95 | 115.05 | 115.85 | 95.73 |
Operating Income Operating Income Growth | 13.7 | 47.78 | 66.75 | 32.62 | 41.34 | 38.84 |
Net Income Net Income Growth | -14.04 | 12.54 | 43.12 | 22.71 | 30.92 | 31.55 |
Earnings Per Share EPS Growth | -0.47 | 0.42 | 1.44 | 0.76 | 1.04 | 1.09 |
EPS Growth | - | -70.83% | 89.47% | -26.92% | -4.19% | 204.32% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Sweden Sweden Growth | 141.11 | 144.66 | 164.83 | 145.28 | 162.77 | 365.22 |
Other Europe Other Europe Growth | 98.54 | 91.16 | 55.74 | 28.24 | 9.72 | - |
Outside Europe Outside Europe Growth | 0.66 | 0.84 | 0.55 | - | - | - |
Denmark Denmark Growth | - | 162.14 | 106.48 | 57.21 | 68.9 | - |
Norway Norway Growth | - | 21.03 | 32.16 | 26.55 | 15.83 | - |
Finland Finland Growth | - | 12.84 | 13.75 | 6.89 | 2.69 | - |
Total Total Growth | 432.36 | 432.66 | 373.52 | 264.17 | 259.91 | 409.75 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 61.1 | 86.76 | 82.4 | 20.47 | 44.43 | 41.2 |
Total Debt Total Debt Growth | 459.69 | 459.34 | 455.71 | 120.09 | 66.62 | 76.1 |
Net Cash (Debt) Net Cash Growth | -398.6 | -372.58 | -373.31 | -99.63 | -22.19 | -34.9 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -13.45 | -12.35 | -12.49 | -3.34 | -0.75 | -1.20 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 21.27 | 28.36 | -24.65 | -11.44 | 27.62 | 41.83 |
Capital Expenditures CapEx Growth | -0.06 | -5.44 | -6.13 | -0.93 | -0.46 | -0.63 |
Free Cash Flow Free Cash Flow Growth | 21.22 | 22.92 | -30.78 | -12.36 | 27.16 | 41.2 |
Free Cash Flow Growth | - | - | - | - | -34.08% | -30.92% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 31.11% | 37.64% | 41.75% | 43.55% | 44.57% | 23.36% |
Operating Margin | 3.17% | 11.04% | 17.87% | 12.35% | 15.90% | 9.48% |
Pretax Margin | -3.53% | 4.21% | 14.55% | 10.83% | 14.99% | 8.78% |
Profit Margin | -3.25% | 2.90% | 11.54% | 8.60% | 11.90% | 7.70% |
FCF Margin | 4.91% | 5.30% | -8.24% | -4.68% | 10.45% | 10.05% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | 128.12 | 47.85 | 54.15 | 35.15 | 30.86 |
Forward PE | 21.43 | 29.17 | 31.21 | 16.99 | - | - |
P/FCF Ratio | 36.61 | 70.10 | - | - | 40.02 | 23.63 |
PS Ratio | 1.80 | 3.71 | 5.53 | 4.65 | 4.18 | 2.38 |